Page 27 - Product Testing News Today

Press release content from Globe Newswire. The AP news staff was not involved in its creation. CytoDyn Files New Protocol with U.S. FDA for 4 Doses of Leronlimab for Critically Ill COVID-19 ... CytoDyn Inc.April 1, 2021 GMT Trial commencement will be expedited by enrolling patients in Brazil, U.K., and Canada while immediate EUA requests are pursued in multiple countries VANCOUVER, Washington, April 01, 2021 (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTC.QB: CYDY), (“CytoDyn” or the “Company”),...

Press release content from Globe Newswire. The AP news staff was not involved in its creation. Inozyme Pharma Expands its Scientific Advisory Board Inozyme Pharma Inc.April 1, 2021 GMT BOSTON, April 01, 2021 (GLOBE NEWSWIRE) -- Inozyme Pharma, Inc., a rare disease biopharmaceutical company developing novel therapeutics for the treatment of disorders of abnormal mineralization, announced today changes to its scientific advisory board (SAB), including the addition of three leading key opinion lea...

WASHINGTON — A group of scientists that ran U.S. clinical trials for coronavirus vaccines last year is launching an ambitious new study to look at their effectiveness, including whether vaccinated people can become infected with COVID-19 and spread it to others. The trials will also look at whether new variants of the coronavirus are able to infect and spread among vaccinated people more than the original virus. The randomized, controlled study began enrolling more than 12,000 college stud...

Press release content from Globe Newswire. The AP news staff was not involved in its creation. Vaccitech Completes $168 Million Series B Financing to Advance Three Clinical Programs Through ... Vaccitech LimitedMarch 17, 2021 GMT OXFORD, United Kingdom, March 17, 2021 (GLOBE NEWSWIRE) -- Vaccitech Ltd (“Vaccitech”), a clinical-stage biopharmaceutical company engaged in the discovery and development of novel immunotherapeutics and vaccines for the treatment and prevention of infectious disea...

Press release content from Globe Newswire. The AP news staff was not involved in its creation. BioPorto Announces the 2020 Annual Report BioPorto A/SMarch 17, 2021 GMT March 17, 2021 Highlights from the 2020 Annual Report Patient enrollment for The NGAL Test clinical trial for pediatrics initiated in June 2020 Initiation of development in April 2020 and advancement to clinical testing of near-patient COVID-19 test based on gRAD in December 2020 CE-mark obtained of NGALds, the first test based o...

Press release content from Business Wire. The AP news staff was not involved in its creation. New Study Presents Evidence of Effectiveness and Safety Of Oleandrin and Phoenix Biotechnology’s PBI-06150 Against SARS-CoV-2 March 17, 2021 GMT An article published last week in the Journal of Biomedicine & Pharmacotherapy ( www.elsevier.com/locate/biopha; Vol 138 (2021) 111457) presents in vitro evidence for significant inhibition of SARS-CoV-2 by oleandrin and a defined extract of N. oleander (...

Press release content from Globe Newswire. The AP news staff was not involved in its creation. Saniona publishes its year-end report for 2020 Saniona ABMarch 17, 2021 GMT PRESS RELEASE Revenue was SEK 8.2 M (7.2 M) Operating loss was SEK -159.4 (-93.6 M) Net loss was SEK -73.4 M (-68.8 M) Earnings per share were SEK -1.79 (-2.67) Diluted earnings per share were SEK -1.75 (-2.67) Q4 2020 (Q4 2019 restated) Revenue was SEK 1.6 M (0.0 M) Operating loss was SEK -68.8 M (-28.2 M) Net ...

Press release content from Globe Newswire. The AP news staff was not involved in its creation. VASCEPA® (Icosapent Ethyl) Found in Prespecified and Post Hoc Analyses to Significantly Reduce ... Amarin Corporation plcMarch 17, 2021 GMT 28% and 32% significant reductions in first and total strokes, respectively, demonstrated with VASCEPA compared to placebo, as well as reductions in first and total ischemic strokes each by 36%, without increasing hemorrhagic stroke, in statin-treated patients wi...

Press release content from Globe Newswire. The AP news staff was not involved in its creation. DeepVerge PLC: Microtox® BT Evaluation of SARS-CoV-2 from breath test with Clinical Samples Deepverge PLCMarch 17, 2021 GMT YORK, United Kingdom, March 17, 2021 (GLOBE NEWSWIRE) -- DeepVerge (LSE:DVRG.L), the environmental and life science AI company, announces initial data for ongoing Phase III clinical studies on the detection of SARS-CoV-2 on breath samples and identification of confirmed COVID...

Press release content from Business Wire. The AP news staff was not involved in its creation. IMV Inc. Announces Fourth Quarter and Full Year 2020 Financial and Operational Results March 17, 2021 GMT DARTMOUTH, Nova Scotia--(BUSINESS WIRE)--Mar 17, 2021-- IMV Inc. (the “Company” or “IMV”) (TSX: IMV; NASDAQ: IMV), a clinical-stage biopharmaceutical company pioneering a novel class of immunotherapies, today announced its financial and operational results for the fourth quarter and year en...